ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Ablynx gets good results for inhaled drug for RSV in infants

Ablynx gets good results for inhaled drug for RSV in infants

September 18, 2012 3:55 am by | 0 Comments

BRUSSELS (Reuters) - Belgian drug developer Ablynx has successfully completed early-stage tests on healthy volunteers for its inhaled treatment for RSV, a virus which is the most common cause of ... Read more